Prior authorizations are a frustrating hurdle for patients who often need immediate treatment – including those in need of prescription drugs. Guests John Hennessy of Valuate and Syam Palakurthy of SamaCare join The IDI to explain the current state of prior authorization – and what’s at stake for pharma and market access.
It’s hard to think of an aspect of health care more vexing than prior authorizations. In fact, prior authorizations are so frustrating that Congress is looking into a legislative solution.
This episode of The IDI we have two guests to explain the state of prior authorization and how to improve the process.
John Hennessy is a principal with Valuate Health with a background in oncology and cancer care.
Syam Palakurthy is co-founder and CEO of SamaCare, a company that streamlines the prior authorization process for medical benefit drugs.
Follow Valuate on LinkedIn.